Zobrazeno 1 - 10
of 217
pro vyhledávání: '"M. S. Piver"'
Autor:
J. Pryse-Davies
Publikováno v:
The Journal of Pathology. 155:181-181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ba8ba647dffd11a8eaabddd8a4c852
https://doi.org/10.1002/path.1711550215
https://doi.org/10.1002/path.1711550215
Autor:
Saundra S. Buys, M. Daly, P. D. P Pharoah, M S Piver, Ingrid Oakley-Girvan, Alice S. Whittemore, Richard A. DiCioccio, Raymond R. Balise, M B Usinowicz, John L. Hopper, Ruby T. Senie, Esther M. John, Susan J. Ramus, Irene L. Andrulis, Kim Garlinghouse-Jones, B. A. J. Ponder
Publikováno v:
British Journal of Cancer
Women with mutations of the genes BRCA1 or BRCA2 are at increased risk of ovarian cancer. Oral contraceptives protect against ovarian cancer in general, but it is not known whether they protect against the disease in carriers of these mutations. We o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438f0ef3119b9b1009794a8f2eac9227
https://doi.org/10.1038/sj.bjc.6602239
https://doi.org/10.1038/sj.bjc.6602239
Publikováno v:
Cancer Genetics and Cytogenetics. 105:93-102
To characterize the involvement of the TP53 tumor suppressor gene in ovarian cancer, mutation analysis of exons 2-11 of TP53 and immunodetection of its protein product, p53, were done in 48 ovarian tumors. Normally, p53 is not immunodetectable. Misse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa56b38e3cadd783410cec4c0cac83a
https://doi.org/10.1016/s0165-4608(98)00011-9
https://doi.org/10.1016/s0165-4608(98)00011-9
Autor:
Nachimuthu Natarajan, M. L. Hicks, Trudy R. Baker, M. S. Piver, Ronald E. Hempling, J. M. Thompson, C. Mettlin
Publikováno v:
Journal of Surgical Oncology. 54:38-44
One hundred seventy-one patients with epithelial ovarian cancer were treated on a prospective protocol of weekly cisplatin induction (1 mg/kg weekly for four courses) followed by monthly cisplatin (50 mg/m2), Adriamycin (50 mg/m2), and cyclophosphami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c4f7f607cf40c936b69f1db6c49a93
https://doi.org/10.1002/jso.2930540111
https://doi.org/10.1002/jso.2930540111
Publikováno v:
Obstetrics and Gynecology Clinics of North America. 19:219-233
Significant progress has been made in the 1980s in early-stage vulvovaginal rhabdomyosarcoma, diethylstilbestrol (DES) clear cell adenocarcinoma of the vagina, and unilateral germ cell tumors of the ovary. In an early state of vulvovaginal rhabdomyos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::485b9fdc6e07ca54d055d215a314bd5c
https://doi.org/10.1016/s0889-8545(21)00511-8
https://doi.org/10.1016/s0889-8545(21)00511-8
Publikováno v:
Immunological Investigations. 20:21-32
The CA 125 antigenic determinant has been shown to be elevated in the serum of ovarian cancer patients and is a useful prognostic marker. The chemical epitope which characterizes the CA 125 antigen is found on a high molecular weight glycoprotein and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8694cda859910a7f7565bef33a0f840c
https://doi.org/10.3109/08820139109054922
https://doi.org/10.3109/08820139109054922
Autor:
M S, Piver, J Y, Lee
Publikováno v:
European journal of gynaecological oncology. 29(2)
Class II modified radical hysterectomy reported in 1974 by Piver, Rutledge and Smith for cervical cancer is an extended hysterectomy that has less dissection of the ureter from the paracervical tissues, ligation of the uterine vessels just medial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::deb2cbba31d20bbaf7c38d61efeee69d
https://pubmed.ncbi.nlm.nih.gov/18459541
https://pubmed.ncbi.nlm.nih.gov/18459541
Autor:
M S, Piver
Publikováno v:
European journal of gynaecological oncology. 22(6)
Since cisplatin is a heavy metal, renal and neurotoxicity is considered to be dose limiting in solid tumors. The current case is unusual in that remission has been maintained in a patient with recurrent epithelial ovarian cancer by cisplatin-based ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f51ce4d9df3b2ba75d9a2490d3004a8
https://pubmed.ncbi.nlm.nih.gov/11874068
https://pubmed.ncbi.nlm.nih.gov/11874068
Autor:
C A, Strittmatter, M S, Piver
Publikováno v:
European journal of gynaecological oncology. 22(5)
PURPOSE AND MATERIALS AND METHODS: Because of the inaccuracies in clinical staging of endometrial cancer, the International Federation of Gynecology and Obstetrics (FIGO) in 1988 changed the staging of endometrial cancer to surgical staging consistin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2b4a737f77c21eed1b650bc1784eca23
https://pubmed.ncbi.nlm.nih.gov/11766728
https://pubmed.ncbi.nlm.nih.gov/11766728
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(8)
Analgesics have been shown to reduce risk for colorectal cancer. Results from three recent reports (D. W. Cramer et al., Lancet, 351: 104-107, 1998; C. Rodriguez et. al., Lancet, 352: 1354-1355, 1998; L. Rosenberg et al., Cancer Epidemiol. Biomark. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ad05233a5018e8a97dac076b33ae948
https://pubmed.ncbi.nlm.nih.gov/11489759
https://pubmed.ncbi.nlm.nih.gov/11489759